We bring automated cell-monitoring solutions for cell & gene therapy, vaccine industry and life sciences applications. Our microscopes are easy-to-use, label-free and non-invasive tools for the three-dimensional, real-time imaging of living cells. Based on patented differential digital holography technology, our advanced systems generate reliable, high-quality holographic images providing highly-reproducible tracking of: - cell density - morphology - cell viability - viral infection kinetics - cell activation status Direct Benefits Our technology can benefit a range of applications, from R&D to manufacturing processes, and enable significant cost reduction and quality improvement. Our microscopes are particularly convenient and robust for automated cell culture monitoring, analysis and quality control.
Looking for a particular Ovizio employee's phone or email?
The Ovizio annual revenue was $1 million in 2026.
André Lebacq is the Vice President of Technology of Ovizio.
18 people are employed at Ovizio.
Ovizio is based in Bruxelles Uccle, Brussels Capital.
The NAICS codes for Ovizio are [54171, 541, 5417, 54, 541713].
The SIC codes for Ovizio are [873, 87].